SCHEDULE 13G/A: Vanguard Group Amends Humana Stake, Discloses 10.65% Passive Ownership

The Vanguard Group has filed an Amendment No. 10 to Schedule 13G, disclosing a 10.65% beneficial ownership stake in Humana Inc. as of December 31, 2024.

Summary

• The Vanguard Group filed an Amendment No. 10 to Schedule 13G with the U.S. Securities and Exchange Commission regarding its ownership in Humana Inc.
• As of December 31, 2024, The Vanguard Group beneficially owns an aggregate of 12,829,185 shares of Humana Inc. Common Stock.
• This ownership represents 10.65% of the total class of Humana Inc. securities.
• The Vanguard Group holds sole voting power over 0 shares and shared voting power over 144,361 shares.
• They maintain sole dispositive power over 12,286,981 shares and shared dispositive power over 542,204 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Humana Inc.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine passive ownership disclosure and does not contain performance or strategic information about the issuer.

Positives

• Indicates continued significant institutional investment by The Vanguard Group in Humana Inc., suggesting a long-term, passive holding strategy by a major asset manager.

Negatives

• This routine ownership disclosure does not contain any specific negative information regarding Humana Inc.'s operations or financial performance.

Risks

• This filing, a routine ownership disclosure, does not contain information regarding specific risks related to Humana Inc.'s business operations or financial condition.

Future Outlook

This Schedule 13G filing does not provide any forward-looking statements or guidance regarding Humana Inc.'s future outlook.

Industry Context

This filing primarily concerns The Vanguard Group's passive investment stake in Humana Inc., a major player in the U.S. healthcare insurance industry. It reflects ongoing institutional investment activity within the sector but does not provide specific insights into broader industry trends or competitive dynamics beyond the ownership stake itself.

Comparison to Industry Standards

• This Schedule 13G filing is a disclosure of beneficial ownership and does not contain financial or operational results that can be compared to industry standards or specific comparable companies.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, confirming continued passive investment.
• Management: Awareness of a large, passive institutional holder.

Next Steps

• This filing does not specify future actions, events, or milestones for Humana Inc. or The Vanguard Group beyond the ongoing passive investment.

Key Dates

Keywords

Humana Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Healthcare, Insurance